- Home
- CRMD vs VMO Comparison
CRMD vs VMO Comparison
Compare CRMD & VMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRMD | VMO |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 590.7M | 642.0M |
| IPO Year | 2009 | 1994 |
Fundamental Metrics
Financial Performance| Metric | CRMD | VMO |
|---|---|---|
| Price | $5.67 | $9.05 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $14.83 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 298.0K |
| Earning Date | 11-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 780.00 | N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | ★ $311,709,000.00 | N/A |
| Revenue This Year | $7.98 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $7.62 | ★ N/A |
| Revenue Growth | ★ 617.03 | N/A |
| 52 Week Low | $5.30 | $8.12 |
| 52 Week High | $13.02 | $10.10 |
Technical Indicators
Market Signals| Indicator | CRMD | VMO |
|---|---|---|
| Relative Strength Index (RSI) | 26.70 | 54.98 |
| Support Level | N/A | $8.58 |
| Resistance Level | $8.81 | $9.84 |
| Average True Range (ATR) | 0.48 | 0.14 |
| MACD | -0.24 | 0.05 |
| Stochastic Oscillator | 8.51 | 73.08 |
Price Performance
Historical ComparisonAbout CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About VMO Invesco Municipal Opportunity Trust
Invesco Municipal Opportunity Trust is a diversified, closed-end management investment company. The investment objective of the company is to provide common shareholders with a high level of current income exempt from federal income tax, consistent with preservation of capital.